Agonist activation of PPARα has been shown to protect against acute myocardial ischemia [46], myocardial remodeling and hypertension [47], hypertrophy [48], diabetic cardiomyopathy [49], atherogenesis [50] and vascular injury [44]. Here, PPARA is linked to diabetic cardiomyopathy.